There are currently 28 active clinical trials seeking participants for Breast Cancer Female research studies. The states with the highest number of trials for Breast Cancer Female participants are NRW, Illinois, Minnesota and Florida.
ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in mTNBC
NCT06351332
Recruiting
This research is being done to evaluate the safety and effectiveness of a drug currently known as Azenosertib (ZN-C3) in combination with the drugs carboplatin and pembrolizumab in metastatic triple-negative breast cancer. The names of the study drugs involved in this study are: Azenosertib (a type of WEE1 inhibitor) Carboplatin (a type of platinum compound) Pembrolizumab (a type of monoclonal antibody)
Gender:
All
Ages:
18 years and above
Trial Updated:
06/17/2024
Locations: Dana-Farber Cancer Institute, Boston, Massachusetts
Conditions: Breast Cancer, Breast Cancer Female, Triple Negative Breast Cancer, Hormone Receptor Negative Malignant Tumor Breast Triple, HER2-negative Breast Cancer
Register for Updates
Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer
NCT04397185
Recruiting
This prospective, multicenter, 1:1 randomized, controlled trial is designed to evaluate the safety and effectiveness of the Breast Cancer Locator (BCL) in subjects with non-palpable invasive breast cancer or ductal carcinoma in situ (DCIS). Subjects will be randomized to breast conserving surgery (BCS) utilizing either the BCL or wire localization (WL) to guide surgery.
Gender:
Female
Ages:
18 years and above
Trial Updated:
06/11/2024
Locations: Arizona Center for Cancer Care, Scottsdale, Arizona +24 locations
Conditions: Breast Cancer Female
Register for Updates
Breaking Through the Brain Fog: An Online Research Study
NCT05444231
Recruiting
This study will investigate the benefits of distinct brain health trainings in breast cancer survivors (age 30-80) with cognitive concerns post-chemotherapy. This study can be completed from the comfort of participant's own home.
Gender:
Female
Ages:
Between 30 years and 80 years
Trial Updated:
06/10/2024
Locations: The Center for BrainHealth at the University of Texas at Dallas, Dallas, Texas
Conditions: Breast Cancer Female
Register for Updates
REJOIN Trial for Older Breast Cancer Survivors
NCT03955627
Recruiting
The purpose of this pilot intervention study is to test the effectiveness of a self-management approach (combining education- and exercise-based strategies) for improving arthralgia (joint pain) associated with Aromatase Inhibitors (AI) in older breast cancer survivors. Survivors will be recruited from local cancer clinics prior to the completion of primary cancer treatment, as arthralgia can occur soon after initiating AI medication. Participants will be randomized to one of two groups: an enha... Read More
Gender:
Female
Ages:
60 years and above
Trial Updated:
06/06/2024
Locations: Wake Forest University Health Sciences, Winston-Salem, North Carolina
Conditions: Breast Cancer Female
Register for Updates
A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN)
NCT06100874
Recruiting
This research study is being done to evaluate the safety and effectiveness of sacituzumab govitecan with trastuzumab (Herceptin, Herceptin Hylecta, or trastuzumab biosimilar) in metastatic HER2+ breast cancer. The names of the study drugs used in this research study are: Sacituzumab govitecan (a type of antibody-drug conjugate) Trastuzumab (Herceptin) (a type of monoclonal antibody) Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta) (a type of recombinant monoclonal antibody) Trastuzumab b... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
05/28/2024
Locations: Dana Farber Cancer Institite, Boston, Massachusetts +1 locations
Conditions: Her 2 Positive Breast Cancer, Breast Cancer Female, Breast Cancer Metastatic
Register for Updates
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
NCT06322888
Recruiting
The goal of this study is to learn more about how exercise might lower the risk of developing breast cancer in women with dense breast tissue by studying changes that occur in breast tissue and blood as a result of participating in an exercise program. The names of the study groups in this study are: Exercise Training Group Waitlist Control Group
Gender:
Female
Ages:
Between 18 years and 59 years
Trial Updated:
05/24/2024
Locations: Brigham and Women's Hospital, Boston, Massachusetts +1 locations
Conditions: Breast Cancer, Breast Cancer Female
Register for Updates
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer
NCT04891068
Recruiting
To determine the effect of low dose azacitidine therapy on tumor infiltrating lymphocytes (TILs) in primary tumors from patients with high-risk early stage breast cancer, paired t-tests will be first used to compare TIL count in pre- and post-treatment specimens.
Gender:
Female
Ages:
18 years and above
Trial Updated:
05/17/2024
Locations: University of Illinois Cancer Center, Chicago, Illinois
Conditions: Breast Cancer Female, Breast Cancer Invasive
Register for Updates
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
NCT05676255
Recruiting
Many breast cancer survivors (estimated 70% in some studies) experience clinically significant depression and/or anxiety in the months and years after finishing cancer treatments. This research will build on the rigor of prior research to reduce breast cancer survivor depression and anxiety with a compassion meditation intervention called CBCT (Cognitively-Based Compassion Training) for online synchronous delivery that is also inclusive of informal caregivers (i.e., adult family members who live... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
05/06/2024
Locations: University of Arizona, Tucson, Arizona
Conditions: Breast Cancer Female, Psychological Distress
Register for Updates
Developing an Internet-Delivered Sexual Health Program for Breast Cancer Survivors, SHINE Trial
NCT06216574
Recruiting
The goal of this clinical trial is to develop an effective internet-delivered program to help breast cancer survivors manage cancer-related sexual concerns. This study is being done to find out if the study approach is better or worse than the usual approach to helping breast cancer survivors manage cancer-related sexual concerns. The usual approach is defined as care most cancer survivors get for their cancer-related sexual concerns. Participants will complete a questionnaire and if they qual... Read More
Gender:
Female
Ages:
18 years and above
Trial Updated:
04/30/2024
Locations: Mercy Hospital Fort Smith, Fort Smith, Arkansas +73 locations
Conditions: Breast Cancer Female
Register for Updates
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
NCT05535192
Recruiting
This research is being done to assess whether an exercise intervention with protein intake support vs a health education and support program will make it easier for women age 65 or older who are receiving chemotherapy for breast cancer to receive all of their planned chemotherapy according to schedule and at the planned dose.
Gender:
Female
Ages:
65 years and above
Trial Updated:
04/04/2024
Locations: Dana Farber Cancer Institute, Boston, Massachusetts +2 locations
Conditions: Breast Cancer, Stage III Breast Cancer, Breast Cancer Female, Stage I Breast Cancer, Stage II Breast Cancer
Register for Updates
Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes
NCT03333122
Recruiting
The purpose of the study is to learn more about the quality of life and satisfaction with breast cancer surgical treatment and education from patient reported outcome data. The data and information obtained from breast cancer patients can be invaluable in counselling patients with a new diagnosis of breast cancer on their expected outcomes and results. The hypothesis is that using prospectively obtained data to guide surgical decision-making and optimize access to surgical procedures would impro... Read More
Gender:
Female
Ages:
18 years and above
Trial Updated:
03/29/2024
Locations: Henry Ford Health System, Detroit, Michigan
Conditions: Breast Cancer Female
Register for Updates
Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI
NCT03137095
Recruiting
Study is enrolling newly diagnosed breast cancer patients about to start chemotherapy and age-matched control participants. The investigator is trying to better understand the prevalence of cognitive difficulties in cancer patients receiving chemotherapy compared to the general population as well as what biological mechanisms may play a role in the development of these difficulties. Patients will be asked to complete six assessments over the course of approximately 5 months. Assessments 1,3, 4.5... Read More
Gender:
Female
Ages:
21 years and above
Trial Updated:
03/28/2024
Locations: University of Rochester, Rochester, New York
Conditions: Cancer Related Cognitive Difficulties, Breast Cancer Female
Register for Updates